367 related articles for article (PubMed ID: 16635072)
1. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
Schellongowski P; Bauer E; Holzinger U; Staudinger T; Frass M; Laczika K; Locker GJ; Quehenberger P; Rabitsch W; Schenk P; Knöbl P
Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
[TBL] [Abstract][Full Text] [Related]
2. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
[TBL] [Abstract][Full Text] [Related]
3. Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans.
Vaccarella G; Pelella R
Minerva Anestesiol; 2003 Sep; 69(9):691-3, 693-5. PubMed ID: 14564239
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
6. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy of sepsis.
Dempfle CE
Thromb Haemost; 2004 Feb; 91(2):213-24. PubMed ID: 14961146
[TBL] [Abstract][Full Text] [Related]
8. Protein C concentrate as adjuvant treatment in neonates with sepsis-induced coagulopathy: a pilot study.
Decembrino L; D'Angelo A; Manzato F; Solinas A; Tumminelli F; De Silvestri A; De Lazzari S; Padovani E; Magarotto M; Chiandetti L; Saia SO; Stronati M
Shock; 2010 Oct; 34(4):341-5. PubMed ID: 20823695
[TBL] [Abstract][Full Text] [Related]
9. [Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis].
Pettenazzo A; Malusa T
Minerva Anestesiol; 2004 May; 70(5):357-63. PubMed ID: 15181416
[TBL] [Abstract][Full Text] [Related]
10. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
11. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate.
Gerson WT; Dickerman JD; Bovill EG; Golden E
Pediatrics; 1993 Feb; 91(2):418-22. PubMed ID: 8424021
[No Abstract] [Full Text] [Related]
12. Sepsis-associated purpura fulminans in adults.
Gamper G; Oschatz E; Herkner H; Paul G; Burgmann H; Janata K; Röggla M; Laggner AN
Wien Klin Wochenschr; 2001 Feb; 113(3-4):107-12. PubMed ID: 11253735
[TBL] [Abstract][Full Text] [Related]
13. Perioperative management of a patient with purpura fulminans syndrome due to protein C deficiency.
Kumagai K; Nishiwaki K; Sato K; Kitamura H; Yano K; Komatsu T; Shimada Y
Can J Anaesth; 2001 Dec; 48(11):1070-4. PubMed ID: 11744581
[TBL] [Abstract][Full Text] [Related]
14. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
[TBL] [Abstract][Full Text] [Related]
15. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
[TBL] [Abstract][Full Text] [Related]
16. Protein C substitution in sepsis-associated purpura fulminans.
Rintala E; Kauppila M; Seppälä OP; Voipio-Pulkki LM; Pettilä V; Rasi V; Kotilainen P
Crit Care Med; 2000 Jul; 28(7):2373-8. PubMed ID: 10921567
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute infectious purpura fulminans with activated protein C.
Lokeshwar MR; Singhal T; Udani SV; Kapadia FN
Indian Pediatr; 2006 Jun; 43(6):535-8. PubMed ID: 16820663
[TBL] [Abstract][Full Text] [Related]
18. [Meningococcal purpura fulminans: treatment with recombinant protein C activator in 3 cases].
Salinas U; Unzueta J; Vidarte MA; Rodrigo MP; Gómez JJ; Aguilera L
Rev Esp Anestesiol Reanim; 2007 Oct; 54(8):503-6. PubMed ID: 17993100
[TBL] [Abstract][Full Text] [Related]
19. [Purpura fulminans in the newborn. Report of two cases successfully treated with heparin and antithrombin III].
Ficuccilli F; Iacobini M; Beglieri MR; Papoff P; Mancuso M; Caradonna A; Donato AI; Colarizi P
Minerva Pediatr; 1997 Dec; 49(12):571-7. PubMed ID: 9577159
[TBL] [Abstract][Full Text] [Related]
20. Use of protein C concentrate in pediatric patients with sepsis.
Silvani P; Camporesi A; Licari E; Wolfler A
Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
